Antiarrhythmics: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
*[[Lidocaine]] | *[[Lidocaine|<sup><sub>Lidocaine</sub></sup>]] | ||
*[[Procainamide]] | *[[Procainamide|<sup><sub>Procainamide</sub></sup>]] | ||
*[[Esmolol]] | *[[Esmolol|<sup><sub>Esmolol</sub></sup>]] | ||
*[[Labetalol]] | *[[Labetalol|<sup><sub>Labetalol</sub></sup>]] | ||
*[[Sotalol]] | *[[Sotalol|<sup><sub>Sotalol</sub></sup>]] | ||
*[[Amiodarone]] | *[[Amiodarone|<sup><sub>Amiodarone</sub></sup>]] | ||
*[[Ibutilide]] | *[[Ibutilide|<sup><sub>Ibutilide</sub></sup>]] | ||
*[[Diltiazem]] | *[[Diltiazem|<sup><sub>Diltiazem</sub></sup>]] | ||
*[[Atropine]] | *[[Atropine|<sup><sub>Atropine</sub></sup>]] | ||
*[[Adenosine]] | *[[Adenosine|<sup><sub>Adenosine</sub></sup>]] | ||
*[[Digoxin]] | *[[Digoxin|<sup><sub>Digoxin</sub></sup>]] | ||
*[[Isoproterenol]] | *[[Isoproterenol|<sup><sub>Isoproterenol</sub></sup>]] | ||
*[[Magnesium]] | *[[Magnesium|<sup><sub>Magnesium</sub></sup>]] | ||
<br> | |||
=== Overview table === | === Overview table === | ||
| Line 28: | Line 29: | ||
| | | | ||
*Quinidine | *Quinidine | ||
*[[Procainamide]] | *[[Procainamide]] | ||
*Disopyramide | *Disopyramide | ||
| Line 41: | Line 42: | ||
| | | | ||
| | | | ||
*[[Lidocaine]] | *[[Lidocaine]] | ||
*Phenytoin | *Phenytoin | ||
*Mexiletine | *Mexiletine | ||
| Line 50: | Line 51: | ||
*treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole | *treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole | ||
*Ventricular tachycardia | *Ventricular tachycardia | ||
*[[ | *[[Atrial Fibrillation (Main)|Atrial fibrillation]] | ||
|- | |- | ||
| Line 71: | Line 72: | ||
| | | | ||
*Propranolol | *Propranolol | ||
*[[Esmolol]] | *[[Esmolol]] | ||
*Timolol | *Timolol | ||
*Metoprolol | *Metoprolol | ||
*Atenolol | *Atenolol | ||
*Bisoprolol | *Bisoprolol | ||
*[[Labetalol]] | *[[Labetalol]] | ||
| Line 87: | Line 88: | ||
| | | | ||
| | | | ||
*[[Amiodarone]] | *[[Amiodarone]] | ||
*[[Sotalol]] | *[[Sotalol]] | ||
*[[Ibutilide]] | *[[Ibutilide]] | ||
*Dofetilide | *Dofetilide | ||
*Dronedarone | *Dronedarone | ||
| Line 104: | Line 105: | ||
*In [[Wolf Parkinson White (WPW)]] | *In [[Wolf Parkinson White (WPW)]] | ||
*(sotalol:) Ventricular tachycardias and Atrial fibrillation | *(sotalol:) Ventricular tachycardias and Atrial fibrillation | ||
*(Ibutilide:) Atrial flutter and [[ | *(Ibutilide:) Atrial flutter and [[Atrial Fibrillation (Main)|Atrial fibrillation]] | ||
|- | |- | ||
| Line 116: | Line 117: | ||
| | | | ||
*prevent recurrence of Paroxysmal supraventricular tachycardia | *prevent recurrence of Paroxysmal supraventricular tachycardia | ||
*reduce Ventricular rate in patients with [[ | *reduce Ventricular rate in patients with [[Atrial Fibrillation (Main)|Atrial fibrillation]] | ||
|- | |- | ||
| Line 122: | Line 123: | ||
| | | | ||
| | | | ||
*[[Adenosine]] | *[[Adenosine]] | ||
*[[Digoxin]] | *[[Digoxin]] | ||
*[[Magnesium]] Sulfate | *[[Magnesium]] Sulfate | ||
| Line 130: | Line 131: | ||
Used in supraventricular arrhythmias, | Used in supraventricular arrhythmias, | ||
Or in the case of Magnesium Sulfate, used in Torsade de Pointe. | Or in the case of Magnesium Sulfate, used in Torsade de Pointe. | ||
|} | |} | ||
<br> | |||
== For Bradyarrythmias: == | == For Bradyarrythmias: == | ||
*[[Atropine]] | *[[Atropine]] | ||
*[[Isoproterenol]] | *[[Isoproterenol]] | ||
=== Source === | === Source === | ||
*Tintinalli | *Tintinalli | ||
*Katzung & Trevor's Pharmacology | *Katzung & Trevor's Pharmacology | ||
[[Category:Drugs]] [[Category:Cards]] | [[Category:Drugs]] [[Category:Cards]] | ||
Revision as of 02:12, 10 January 2012
- Lidocaine
- Procainamide
- Esmolol
- Labetalol
- Sotalol
- Amiodarone
- Ibutilide
- Diltiazem
- Atropine
- Adenosine
- Digoxin
- Isoproterenol
- Magnesium
Overview table
| Class | Known as | Examples | Mechanism | Clinical uses |
|---|---|---|---|---|
| Ia | fast-channel blockers-Affect QRS complex |
|
(Na+) channel block (intermediate association/dissociation) |
|
| Ib- Do not affect QRS complex |
|
(Na+) channel block (fast association/dissociation) |
| |
| Ic |
|
(Na+) channel block (slow association/dissociation) |
| |
| II | Beta-blockers | beta blocking Propranolol also shows some class I action |
| |
| III |
|
K+ channel blocker Sotalol is also a beta blocker Amiodarone has Class I, II, and III activity |
| |
| IV | slow-channel blockers |
|
Ca2+ channel blocker |
|
| V | Work by other or unknown mechanisms (Direct nodal inhibition). |
Used in supraventricular arrhythmias, Or in the case of Magnesium Sulfate, used in Torsade de Pointe. |
For Bradyarrythmias:
Source
- Tintinalli
- Katzung & Trevor's Pharmacology